Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Report

USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Oct 19, 2022
  • PAGES：155
  • REPORT CODE：GMM1298583
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Merck & Co Inc

    • Heron Therapeutics

    • GlaxoSmithKline Plc

    • Tesaro

    • Helsinn Group

    By Type:

    • Corticosteroids

    • Serotonin Antagonists

    • Dopamine Antagonists

    • NK-1 Inhibitors

    • Cannabinoids

    • Motion Sickness Treatments

    • Anti-anxiety Drugs

    • Other

    By End-User:

    • High Emetic Risk Intravenous Chemotherapy

    • Moderate Emetic Risk Intravenous Chemotherapy

    • Low and Minimal Emetic Risk Intravenous Chemotherapy

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Corticosteroids from 2016 to 2027

      • 1.3.2 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Serotonin Antagonists from 2016 to 2027

      • 1.3.3 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Dopamine Antagonists from 2016 to 2027

      • 1.3.4 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of NK-1 Inhibitors from 2016 to 2027

      • 1.3.5 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Cannabinoids from 2016 to 2027

      • 1.3.6 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Motion Sickness Treatments from 2016 to 2027

      • 1.3.7 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Anti-anxiety Drugs from 2016 to 2027

      • 1.3.8 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of High Emetic Risk Intravenous Chemotherapy from 2016 to 2027

      • 1.4.2 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Moderate Emetic Risk Intravenous Chemotherapy from 2016 to 2027

      • 1.4.3 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Low and Minimal Emetic Risk Intravenous Chemotherapy from 2016 to 2027

      • 1.4.4 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Corticosteroids

      • 3.4.2 Market Size and Growth Rate of Serotonin Antagonists

      • 3.4.3 Market Size and Growth Rate of Dopamine Antagonists

      • 3.4.4 Market Size and Growth Rate of NK-1 Inhibitors

      • 3.4.5 Market Size and Growth Rate of Cannabinoids

      • 3.4.6 Market Size and Growth Rate of Motion Sickness Treatments

      • 3.4.7 Market Size and Growth Rate of Anti-anxiety Drugs

      • 3.4.8 Market Size and Growth Rate of Other

    4 Segmentation of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in High Emetic Risk Intravenous Chemotherapy

      • 4.4.2 Market Size and Growth Rate of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in Moderate Emetic Risk Intravenous Chemotherapy

      • 4.4.3 Market Size and Growth Rate of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in Low and Minimal Emetic Risk Intravenous Chemotherapy

      • 4.4.4 Market Size and Growth Rate of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in Other

    5 Market Analysis by Regions

    • 5.1 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Production Analysis by Regions

    • 5.2 USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis

    • 6.1 West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major Types

    • 6.2 West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major End-Users

    7 South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis

    • 7.1 South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major Types

    • 7.2 South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major End-Users

    8 Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis

    • 8.1 Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major Types

    • 8.2 Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major End-Users

    9 Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis

    • 9.1 Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major Types

    • 9.2 Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Merck & Co Inc

        • 10.1.1 Merck & Co Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Heron Therapeutics

        • 10.2.1 Heron Therapeutics Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 GlaxoSmithKline Plc

        • 10.3.1 GlaxoSmithKline Plc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Tesaro

        • 10.4.1 Tesaro Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Helsinn Group

        • 10.5.1 Helsinn Group Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Corticosteroids from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Serotonin Antagonists from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Dopamine Antagonists from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of NK-1 Inhibitors from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Cannabinoids from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Motion Sickness Treatments from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Anti-anxiety Drugs from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of High Emetic Risk Intravenous Chemotherapy from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Moderate Emetic Risk Intravenous Chemotherapy from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Low and Minimal Emetic Risk Intravenous Chemotherapy from 2016 to 2027

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Corticosteroids

    • Figure Market Size and Growth Rate of Serotonin Antagonists

    • Figure Market Size and Growth Rate of Dopamine Antagonists

    • Figure Market Size and Growth Rate of NK-1 Inhibitors

    • Figure Market Size and Growth Rate of Cannabinoids

    • Figure Market Size and Growth Rate of Motion Sickness Treatments

    • Figure Market Size and Growth Rate of Anti-anxiety Drugs

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of High Emetic Risk Intravenous Chemotherapy

    • Figure Market Size and Growth Rate of Moderate Emetic Risk Intravenous Chemotherapy

    • Figure Market Size and Growth Rate of Low and Minimal Emetic Risk Intravenous Chemotherapy

    • Figure Market Size and Growth Rate of Other

    • Table USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Production by Regions

    • Table USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Production Share by Regions

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Production Share by Regions in 2016

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Production Share by Regions in 2021

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Production Share by Regions in 2027

    • Table USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Regions

    • Table USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Regions

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Regions in 2016

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Regions in 2021

    • Figure USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Regions in 2027

    • Table West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Types from 2016 to 2027

    • Table West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types from 2016 to 2027

    • Figure West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2016

    • Figure West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2021

    • Figure West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2027

    • Table West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by End-Users from 2016 to 2027

    • Table West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2016

    • Figure West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2021

    • Figure West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2027

    • Table South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Types from 2016 to 2027

    • Table South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types from 2016 to 2027

    • Figure South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2016

    • Figure South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2021

    • Figure South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2027

    • Table South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by End-Users from 2016 to 2027

    • Table South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2016

    • Figure South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2021

    • Figure South USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2027

    • Table Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Types from 2016 to 2027

    • Table Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2016

    • Figure Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2021

    • Figure Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2027

    • Table Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2016

    • Figure Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2021

    • Figure Middle West USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2027

    • Table Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by Types from 2016 to 2027

    • Table Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2016

    • Figure Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2021

    • Figure Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2027

    • Table Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2016

    • Figure Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2021

    • Figure Northeast USA Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Merck & Co Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc

    • Figure Revenue and Market Share Analysis of Merck & Co Inc

    • Table Product and Service Introduction of Merck & Co Inc

    • Table Company Profile and Development Status of Heron Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heron Therapeutics

    • Figure Sales and Growth Rate Analysis of Heron Therapeutics

    • Figure Revenue and Market Share Analysis of Heron Therapeutics

    • Table Product and Service Introduction of Heron Therapeutics

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Tesaro

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tesaro

    • Figure Sales and Growth Rate Analysis of Tesaro

    • Figure Revenue and Market Share Analysis of Tesaro

    • Table Product and Service Introduction of Tesaro

    • Table Company Profile and Development Status of Helsinn Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helsinn Group

    • Figure Sales and Growth Rate Analysis of Helsinn Group

    • Figure Revenue and Market Share Analysis of Helsinn Group

    • Table Product and Service Introduction of Helsinn Group


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US